Skip to main content
Top
Published in: Cardiovascular Diabetology 1/2012

Open Access 01-12-2012 | Original investigation

2-h postchallenge plasma glucose predicts cardiovascular events in patients with myocardial infarction without known diabetes mellitus

Authors: Loghman Henareh, Stefan Agewall

Published in: Cardiovascular Diabetology | Issue 1/2012

Login to get access

Abstract

Background and purpose

The incidence of cardiovascular events remains high in patients with myocardial infarction (MI) despite advances in current therapies. New and better methods for identifying patients at high risk of recurrent cardiovascular (CV) events are needed. This study aimed to analyze the predictive value of an oral glucose tolerance test (OGTT) in patients with acute myocardial infarction without known diabetes mellitus (DM).

Methods

The prospective cohort study consisted of 123 men and women aged between 31–80 years who had suffered a previous MI 3–12 months before the examinations. The exclusion criteria were known diabetes mellitus. Patients were followed up over 6.03 ± 1.36 years for CV death, recurrent MI, stroke and unstable angina pectoris. A standard OGTT was performed at baseline.

Results

2-h plasma glucose (HR, 1.27, 95% CI, 1.00 to 1.62; P < 0.05) and smoking (HR, 3.56, 95% CI, 1.02 to 12.38; P < 0.05) proved to be independent predictors of CV events in multivariate statistical analysis after adjustments for age, sex, total cholesterol, and other baseline characteristics.

Conclusions

In this study population, with previous MI and without known DM, 2-h PG and smoking were significant predictors of CV death, recurrent MI, stroke and unstable angina pectoris, independent of baseline characteristics and medical treatment.
Appendix
Available only for authorised users
Literature
1.
go back to reference Henareh L, Berglund M, Agewall S: Should oral glucose tolerance test be a routine examination after a myocardial infarction?. Int J Cardiol. 2004, 97 (1): 21-24. 10.1016/j.ijcard.2003.06.023.CrossRefPubMed Henareh L, Berglund M, Agewall S: Should oral glucose tolerance test be a routine examination after a myocardial infarction?. Int J Cardiol. 2004, 97 (1): 21-24. 10.1016/j.ijcard.2003.06.023.CrossRefPubMed
2.
go back to reference Conaway DG, O'Keefe JH, Reid KJ, Spertus J: Frequency of undiagnosed diabetes mellitus in patients with acute coronary syndrome. Am J Cardiol. 2005, 96 (3): 363-365. 10.1016/j.amjcard.2005.03.076.CrossRefPubMed Conaway DG, O'Keefe JH, Reid KJ, Spertus J: Frequency of undiagnosed diabetes mellitus in patients with acute coronary syndrome. Am J Cardiol. 2005, 96 (3): 363-365. 10.1016/j.amjcard.2005.03.076.CrossRefPubMed
3.
go back to reference Leiter LA, Ceriello A, Davidson JA, Hanefeld M, Monnier L, Owens DR, Tajima N, Tuomilehto J: Postprandial glucose regulation: new data and new implications. Clin Ther. 2005, 27 (Suppl B): S42-S56.CrossRefPubMed Leiter LA, Ceriello A, Davidson JA, Hanefeld M, Monnier L, Owens DR, Tajima N, Tuomilehto J: Postprandial glucose regulation: new data and new implications. Clin Ther. 2005, 27 (Suppl B): S42-S56.CrossRefPubMed
4.
go back to reference Henareh L, Jogestrand T, Agewall S: Glucose intolerance is associated with C-reactive protein and intima-media anatomy of the common carotid artery in patients with coronary heart disease. Diabet Med. 2005, 22 (9): 1212-1217. 10.1111/j.1464-5491.2005.01577.x.CrossRefPubMed Henareh L, Jogestrand T, Agewall S: Glucose intolerance is associated with C-reactive protein and intima-media anatomy of the common carotid artery in patients with coronary heart disease. Diabet Med. 2005, 22 (9): 1212-1217. 10.1111/j.1464-5491.2005.01577.x.CrossRefPubMed
5.
go back to reference Hanefeld M, Fischer S, Julius U, Schulze J, Schwanebeck U, Schmechel H, Ziegelasch HJ, Lindner J: Risk factors for myocardial infarction and death in newly detected NIDDM: the diabetes intervention study, 11-year follow-up. Diabetologia. 1996, 39 (12): 1577-1583. 10.1007/s001250050617.CrossRefPubMed Hanefeld M, Fischer S, Julius U, Schulze J, Schwanebeck U, Schmechel H, Ziegelasch HJ, Lindner J: Risk factors for myocardial infarction and death in newly detected NIDDM: the diabetes intervention study, 11-year follow-up. Diabetologia. 1996, 39 (12): 1577-1583. 10.1007/s001250050617.CrossRefPubMed
6.
go back to reference Giugliano D, Ceriello A, Paolisso G: Oxidative stress and diabetic vascular complications. Diabetes Care. 1996, 19 (3): 257-267. 10.2337/diacare.19.3.257.CrossRefPubMed Giugliano D, Ceriello A, Paolisso G: Oxidative stress and diabetic vascular complications. Diabetes Care. 1996, 19 (3): 257-267. 10.2337/diacare.19.3.257.CrossRefPubMed
7.
go back to reference Schmidt AM, Yan SD, Wautier JL, Stern D: Activation of receptor for advanced glycation end products: a mechanism for chronic vascular dysfunction in diabetic vasculopathy and atherosclerosis. Circ Res. 1999, 84 (5): 489-497. 10.1161/01.RES.84.5.489.CrossRefPubMed Schmidt AM, Yan SD, Wautier JL, Stern D: Activation of receptor for advanced glycation end products: a mechanism for chronic vascular dysfunction in diabetic vasculopathy and atherosclerosis. Circ Res. 1999, 84 (5): 489-497. 10.1161/01.RES.84.5.489.CrossRefPubMed
8.
go back to reference Crisby M, Kublickiene K, Henareh L, Agewall S: Circulating levels of autoantibodies to oxidized low-density lipoprotein and C-reactive protein levels correlate with endothelial function in resistance arteries in men with coronary heart disease. Heart Vessels. 2009, 24 (2): 90-95. 10.1007/s00380-008-1089-y.CrossRefPubMed Crisby M, Kublickiene K, Henareh L, Agewall S: Circulating levels of autoantibodies to oxidized low-density lipoprotein and C-reactive protein levels correlate with endothelial function in resistance arteries in men with coronary heart disease. Heart Vessels. 2009, 24 (2): 90-95. 10.1007/s00380-008-1089-y.CrossRefPubMed
9.
go back to reference Thygesen K, Alpert JS, White HD, Jaffe AS, Apple FS, Galvani M, Katus HA, Newby LK, Ravkilde J, Chaitman B, et al: Universal definition of myocardial infarction. Circulation. 2007, 116 (22): 2634-2653. 10.1161/CIRCULATIONAHA.107.187397.CrossRefPubMed Thygesen K, Alpert JS, White HD, Jaffe AS, Apple FS, Galvani M, Katus HA, Newby LK, Ravkilde J, Chaitman B, et al: Universal definition of myocardial infarction. Circulation. 2007, 116 (22): 2634-2653. 10.1161/CIRCULATIONAHA.107.187397.CrossRefPubMed
10.
go back to reference Diagnosis and classification of diabetes mellitus. Diabetes Care. 2010, 33 (Suppl 1): S62-S69. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2010, 33 (Suppl 1): S62-S69.
11.
go back to reference Schiller NB, Shah PM, Crawford M, DeMaria A, Devereux R, Feigenbaum H, Gutgesell H, Reichek N, Sahn D, Schnittger I, et al: Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. american society of echocardiography committee on standards, subcommittee on quantitation of two-dimensional echocardiograms. J Am Soc Echocardiogr. 1989, 2 (5): 358-367.CrossRefPubMed Schiller NB, Shah PM, Crawford M, DeMaria A, Devereux R, Feigenbaum H, Gutgesell H, Reichek N, Sahn D, Schnittger I, et al: Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. american society of echocardiography committee on standards, subcommittee on quantitation of two-dimensional echocardiograms. J Am Soc Echocardiogr. 1989, 2 (5): 358-367.CrossRefPubMed
12.
go back to reference Barr EL, Zimmet PZ, Welborn TA, Jolley D, Magliano DJ, Dunstan DW, Cameron AJ, Dwyer T, Taylor HR, Tonkin AM, et al: Risk of cardiovascular and all-cause mortality in individuals with diabetes mellitus, impaired fasting glucose, and impaired glucose tolerance: the australian diabetes, obesity, and lifestyle study (AusDiab). Circulation. 2007, 116 (2): 151-157. 10.1161/CIRCULATIONAHA.106.685628.CrossRefPubMed Barr EL, Zimmet PZ, Welborn TA, Jolley D, Magliano DJ, Dunstan DW, Cameron AJ, Dwyer T, Taylor HR, Tonkin AM, et al: Risk of cardiovascular and all-cause mortality in individuals with diabetes mellitus, impaired fasting glucose, and impaired glucose tolerance: the australian diabetes, obesity, and lifestyle study (AusDiab). Circulation. 2007, 116 (2): 151-157. 10.1161/CIRCULATIONAHA.106.685628.CrossRefPubMed
13.
go back to reference Meigs JB, Nathan DM, D'Agostino RB, Wilson PW: Fasting and postchallenge glycemia and cardiovascular disease risk: the Framingham offspring study. Diabetes Care. 2002, 25 (10): 1845-1850. 10.2337/diacare.25.10.1845.CrossRefPubMed Meigs JB, Nathan DM, D'Agostino RB, Wilson PW: Fasting and postchallenge glycemia and cardiovascular disease risk: the Framingham offspring study. Diabetes Care. 2002, 25 (10): 1845-1850. 10.2337/diacare.25.10.1845.CrossRefPubMed
14.
go back to reference Tominaga M, Eguchi H, Manaka H, Igarashi K, Kato T, Sekikawa A: Impaired glucose tolerance is a risk factor for cardiovascular disease, but not impaired fasting glucose. The funagata diabetes study. Diabetes care. 1999, 22 (6): 920-924. 10.2337/diacare.22.6.920.CrossRefPubMed Tominaga M, Eguchi H, Manaka H, Igarashi K, Kato T, Sekikawa A: Impaired glucose tolerance is a risk factor for cardiovascular disease, but not impaired fasting glucose. The funagata diabetes study. Diabetes care. 1999, 22 (6): 920-924. 10.2337/diacare.22.6.920.CrossRefPubMed
15.
go back to reference Glucose tolerance and mortality: comparison of WHO and American Diabetes Association diagnostic criteria: The DECODE study group. European Diabetes Epidemiology Group. Diabetes Epidemiology: Collaborative analysis Of Diagnostic criteria in Europe. Lancet. 1999, 354 (9179): 617-621.CrossRef Glucose tolerance and mortality: comparison of WHO and American Diabetes Association diagnostic criteria: The DECODE study group. European Diabetes Epidemiology Group. Diabetes Epidemiology: Collaborative analysis Of Diagnostic criteria in Europe. Lancet. 1999, 354 (9179): 617-621.CrossRef
16.
go back to reference Bartnik M, Malmberg K, Norhammar A, Tenerz A, Ohrvik J, Ryden L: Newly detected abnormal glucose tolerance: an important predictor of long-term outcome after myocardial infarction. Eur Heart J. 2004, 25 (22): 1990-1997. 10.1016/j.ehj.2004.09.021.CrossRefPubMed Bartnik M, Malmberg K, Norhammar A, Tenerz A, Ohrvik J, Ryden L: Newly detected abnormal glucose tolerance: an important predictor of long-term outcome after myocardial infarction. Eur Heart J. 2004, 25 (22): 1990-1997. 10.1016/j.ehj.2004.09.021.CrossRefPubMed
17.
go back to reference Tamita K, Katayama M, Takagi T, Akasaka T, Yamamuro A, Kaji S, Morioka S, Kihara Y: Impact of newly diagnosed abnormal glucose tolerance on long-term prognosis in patients with acute myocardial infarction. Circulation journal: official journal of the Japanese circulation society. 2007, 71 (6): 834-841. 10.1253/circj.71.834.CrossRef Tamita K, Katayama M, Takagi T, Akasaka T, Yamamuro A, Kaji S, Morioka S, Kihara Y: Impact of newly diagnosed abnormal glucose tolerance on long-term prognosis in patients with acute myocardial infarction. Circulation journal: official journal of the Japanese circulation society. 2007, 71 (6): 834-841. 10.1253/circj.71.834.CrossRef
18.
go back to reference Qiao Q, Pyorala K, Pyorala M, Nissinen A, Lindstrom J, Tilvis R, Tuomilehto J: Two-hour glucose is a better risk predictor for incident coronary heart disease and cardiovascular mortality than fasting glucose. Eur Heart J. 2002, 23 (16): 1267-1275. 10.1053/euhj.2001.3113.CrossRefPubMed Qiao Q, Pyorala K, Pyorala M, Nissinen A, Lindstrom J, Tilvis R, Tuomilehto J: Two-hour glucose is a better risk predictor for incident coronary heart disease and cardiovascular mortality than fasting glucose. Eur Heart J. 2002, 23 (16): 1267-1275. 10.1053/euhj.2001.3113.CrossRefPubMed
19.
go back to reference Kitada S, Otsuka Y, Kokubu N, Kasahara Y, Kataoka Y, Noguchi T, Goto Y, Kimura G, Nonogi H: Post-load hyperglycemia as an important predictor of long-term adverse cardiac events after acute myocardial infarction: a scientific study. Cardiovasc Diabetol. 2010, 9: 75-10.1186/1475-2840-9-75.PubMedCentralCrossRefPubMed Kitada S, Otsuka Y, Kokubu N, Kasahara Y, Kataoka Y, Noguchi T, Goto Y, Kimura G, Nonogi H: Post-load hyperglycemia as an important predictor of long-term adverse cardiac events after acute myocardial infarction: a scientific study. Cardiovasc Diabetol. 2010, 9: 75-10.1186/1475-2840-9-75.PubMedCentralCrossRefPubMed
20.
go back to reference Schinner S, Futh R, Kempf K, Martin S, Willenberg HS, Schott M, Dinh W, Scherbaum WA, Lankisch M: A progressive increase in cardiovascular risk assessed by coronary angiography in non-diabetic patients at sub-diabetic glucose levels. Cardiovasc Diabetol. 2011, 10: 56-10.1186/1475-2840-10-56.PubMedCentralCrossRefPubMed Schinner S, Futh R, Kempf K, Martin S, Willenberg HS, Schott M, Dinh W, Scherbaum WA, Lankisch M: A progressive increase in cardiovascular risk assessed by coronary angiography in non-diabetic patients at sub-diabetic glucose levels. Cardiovasc Diabetol. 2011, 10: 56-10.1186/1475-2840-10-56.PubMedCentralCrossRefPubMed
21.
go back to reference Henkel E, Kohler C, Temelkova-Kurktschiev T, Hanefeld M: Predictors of abnormal glucose tolerance in persons at risk of type 2 diabetes: the RIAD study. Dtsch Med Wochenschr. 2002, 127 (18): 953-957. 10.1055/s-2002-26731.CrossRefPubMed Henkel E, Kohler C, Temelkova-Kurktschiev T, Hanefeld M: Predictors of abnormal glucose tolerance in persons at risk of type 2 diabetes: the RIAD study. Dtsch Med Wochenschr. 2002, 127 (18): 953-957. 10.1055/s-2002-26731.CrossRefPubMed
22.
go back to reference Chu CS, Lee KT, Cheng KH, Lee MY, Kuo HF, Lin TH, Su HM, Voon WC, Sheu SH, Lai WT: Postchallenge responses of nitrotyrosine and TNF-alpha during 75-g oral glucose tolerance test are associated with the presence of coronary artery diseases in patients with prediabetes. Cardiovasc Diabetol. 2012, 11: 21-10.1186/1475-2840-11-21.PubMedCentralCrossRefPubMed Chu CS, Lee KT, Cheng KH, Lee MY, Kuo HF, Lin TH, Su HM, Voon WC, Sheu SH, Lai WT: Postchallenge responses of nitrotyrosine and TNF-alpha during 75-g oral glucose tolerance test are associated with the presence of coronary artery diseases in patients with prediabetes. Cardiovasc Diabetol. 2012, 11: 21-10.1186/1475-2840-11-21.PubMedCentralCrossRefPubMed
23.
go back to reference Henareh L, Lind B, Brodin LA, Agewall S: Disturbed glucose metabolism is associated with left ventricular dysfunction using tissue doppler imaging in patients with myocardial infarction. Clin Physiol Funct Imaging. 2007, 27 (1): 60-66. 10.1111/j.1475-097X.2007.00717.x.CrossRefPubMed Henareh L, Lind B, Brodin LA, Agewall S: Disturbed glucose metabolism is associated with left ventricular dysfunction using tissue doppler imaging in patients with myocardial infarction. Clin Physiol Funct Imaging. 2007, 27 (1): 60-66. 10.1111/j.1475-097X.2007.00717.x.CrossRefPubMed
24.
go back to reference Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ. 2002, 324 (7329): 71-86. 10.1136/bmj.324.7329.71. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ. 2002, 324 (7329): 71-86. 10.1136/bmj.324.7329.71.
25.
go back to reference Metoprolol in acute myocardial infarction (MIAMI): A randomised placebo-controlled international trial. The MIAMI trial research group. Eur Heart J. 1985, 6 (3): 199-226. Metoprolol in acute myocardial infarction (MIAMI): A randomised placebo-controlled international trial. The MIAMI trial research group. Eur Heart J. 1985, 6 (3): 199-226.
26.
go back to reference Yusuf S, Sleight P, Pogue J, Bosch J, Davies R, Dagenais G: Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med. 2000, 342 (3): 145-153.CrossRefPubMed Yusuf S, Sleight P, Pogue J, Bosch J, Davies R, Dagenais G: Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med. 2000, 342 (3): 145-153.CrossRefPubMed
27.
go back to reference Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin survival study (4 S). Lancet. 1994, 344 (8934): 1383-1389. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin survival study (4 S). Lancet. 1994, 344 (8934): 1383-1389.
28.
go back to reference Al-Delaimy WK, Willett WC, Manson JE, Speizer FE, Hu FB: Smoking and mortality among women with type 2 diabetes: The nurses' health study cohort. Diabetes Care. 2001, 24 (12): 2043-2048. 10.2337/diacare.24.12.2043.CrossRefPubMed Al-Delaimy WK, Willett WC, Manson JE, Speizer FE, Hu FB: Smoking and mortality among women with type 2 diabetes: The nurses' health study cohort. Diabetes Care. 2001, 24 (12): 2043-2048. 10.2337/diacare.24.12.2043.CrossRefPubMed
29.
go back to reference Fuller JH, Stevens LK, Wang SL: Risk factors for cardiovascular mortality and morbidity: the WHO mutinational study of vascular disease in diabetes. Diabetologia. 2001, 44 (Suppl 2): S54-S64.CrossRefPubMed Fuller JH, Stevens LK, Wang SL: Risk factors for cardiovascular mortality and morbidity: the WHO mutinational study of vascular disease in diabetes. Diabetologia. 2001, 44 (Suppl 2): S54-S64.CrossRefPubMed
30.
go back to reference Rimm EB, Chan J, Stampfer MJ, Colditz GA, Willett WC: Prospective study of cigarette smoking, alcohol use, and the risk of diabetes in men. BMJ. 1995, 310 (6979): 555-559. 10.1136/bmj.310.6979.555.PubMedCentralCrossRefPubMed Rimm EB, Chan J, Stampfer MJ, Colditz GA, Willett WC: Prospective study of cigarette smoking, alcohol use, and the risk of diabetes in men. BMJ. 1995, 310 (6979): 555-559. 10.1136/bmj.310.6979.555.PubMedCentralCrossRefPubMed
31.
go back to reference Manson JE, Ajani UA, Liu S, Nathan DM, Hennekens CH: A prospective study of cigarette smoking and the incidence of diabetes mellitus among US male physicians. Am J Med. 2000, 109 (7): 538-542. 10.1016/S0002-9343(00)00568-4.CrossRefPubMed Manson JE, Ajani UA, Liu S, Nathan DM, Hennekens CH: A prospective study of cigarette smoking and the incidence of diabetes mellitus among US male physicians. Am J Med. 2000, 109 (7): 538-542. 10.1016/S0002-9343(00)00568-4.CrossRefPubMed
32.
go back to reference Fagard RH, Nilsson PM: Smoking and diabetes--the double health hazard. Prim Care Diabetes. 2009, 3 (4): 205-209. 10.1016/j.pcd.2009.09.003.CrossRefPubMed Fagard RH, Nilsson PM: Smoking and diabetes--the double health hazard. Prim Care Diabetes. 2009, 3 (4): 205-209. 10.1016/j.pcd.2009.09.003.CrossRefPubMed
33.
go back to reference Ceriello A, Bortolotti N, Motz E, Crescentini A, Lizzio S, Russo A, Tonutti L, Taboga C: Meal-generated oxidative stress in type 2 diabetic patients. Diabetes Care. 1998, 21 (9): 1529-1533. 10.2337/diacare.21.9.1529.CrossRefPubMed Ceriello A, Bortolotti N, Motz E, Crescentini A, Lizzio S, Russo A, Tonutti L, Taboga C: Meal-generated oxidative stress in type 2 diabetic patients. Diabetes Care. 1998, 21 (9): 1529-1533. 10.2337/diacare.21.9.1529.CrossRefPubMed
34.
go back to reference Marfella R, Quagliaro L, Nappo F, Ceriello A, Giugliano D: Acute hyperglycemia induces an oxidative stress in healthy subjects. J Clin Invest. 2001, 108 (4): 635-636.PubMedCentralCrossRefPubMed Marfella R, Quagliaro L, Nappo F, Ceriello A, Giugliano D: Acute hyperglycemia induces an oxidative stress in healthy subjects. J Clin Invest. 2001, 108 (4): 635-636.PubMedCentralCrossRefPubMed
35.
go back to reference Tomiyama H, Kimura Y, Okazaki R, Kushiro T, Abe M, Kuwabara Y, Yoshida H, Kuwata S, Kinouchi T, Doba N: Close relationship of abnormal glucose tolerance with endothelial dysfunction in hypertension. Hypertension. 2000, 36 (2): 245-249. 10.1161/01.HYP.36.2.245.CrossRefPubMed Tomiyama H, Kimura Y, Okazaki R, Kushiro T, Abe M, Kuwabara Y, Yoshida H, Kuwata S, Kinouchi T, Doba N: Close relationship of abnormal glucose tolerance with endothelial dysfunction in hypertension. Hypertension. 2000, 36 (2): 245-249. 10.1161/01.HYP.36.2.245.CrossRefPubMed
36.
go back to reference Kawano H, Motoyama T, Hirashima O, Hirai N, Miyao Y, Sakamoto T, Kugiyama K, Ogawa H, Yasue H: Hyperglycemia rapidly suppresses flow-mediated endothelium-dependent vasodilation of brachial artery. J Am Coll Cardiol. 1999, 34 (1): 146-154. 10.1016/S0735-1097(99)00168-0.CrossRefPubMed Kawano H, Motoyama T, Hirashima O, Hirai N, Miyao Y, Sakamoto T, Kugiyama K, Ogawa H, Yasue H: Hyperglycemia rapidly suppresses flow-mediated endothelium-dependent vasodilation of brachial artery. J Am Coll Cardiol. 1999, 34 (1): 146-154. 10.1016/S0735-1097(99)00168-0.CrossRefPubMed
37.
go back to reference Heitzer T, Schlinzig T, Krohn K, Meinertz T, Munzel T: Endothelial dysfunction, oxidative stress, and risk of cardiovascular events in patients with coronary artery disease. Circulation. 2001, 104 (22): 2673-2678. 10.1161/hc4601.099485.CrossRefPubMed Heitzer T, Schlinzig T, Krohn K, Meinertz T, Munzel T: Endothelial dysfunction, oxidative stress, and risk of cardiovascular events in patients with coronary artery disease. Circulation. 2001, 104 (22): 2673-2678. 10.1161/hc4601.099485.CrossRefPubMed
38.
go back to reference Haenni A, Andersson PE, Lind L, Berne C, Lithell H: Electrolyte changes and metabolic effects of lisinopril/bendrofluazide treatment. Results from a randomized, double-blind study with parallel groups. Am J Hypertens. 1994, 7 (7 Pt 1): 615-622.PubMed Haenni A, Andersson PE, Lind L, Berne C, Lithell H: Electrolyte changes and metabolic effects of lisinopril/bendrofluazide treatment. Results from a randomized, double-blind study with parallel groups. Am J Hypertens. 1994, 7 (7 Pt 1): 615-622.PubMed
Metadata
Title
2-h postchallenge plasma glucose predicts cardiovascular events in patients with myocardial infarction without known diabetes mellitus
Authors
Loghman Henareh
Stefan Agewall
Publication date
01-12-2012
Publisher
BioMed Central
Published in
Cardiovascular Diabetology / Issue 1/2012
Electronic ISSN: 1475-2840
DOI
https://doi.org/10.1186/1475-2840-11-93

Other articles of this Issue 1/2012

Cardiovascular Diabetology 1/2012 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.